Table 2. Result of antimicrobial susceptibility testing of blood culture.
Antimicrobial susceptibility was determined by the broth microdilution method. Breakpoints comply with the Clinical and Laboratory Standard Institute (CLSI) guidelines.
Bacteria: Edwardsiella tarda | ||
Antibiotics | Interpretation | Minimum inhibitory concentration (μg/mL) |
Ampicillin | Susceptible | <8 |
Ampicillin/sulbactam | Susceptible | <8 |
Piperacillin | Susceptible | <8 |
Piperacillin/tazobactam | Susceptible | <16 |
Cefazolin | Susceptible | <4 |
Cefaclor | Susceptible | <8 |
Cefotiam | Susceptible | <8 |
Cefmetazole | Susceptible | <8 |
Flomoxef | Susceptible | <8 |
Cefoperazone/sulbactam | Susceptible | <16 |
Cefotaxime | Susceptible | <1 |
Ceftazidime | Susceptible | <4 |
Ceftriaxone | Susceptible | <1 |
Cefepime | Susceptible | <2 |
Cefcapene pivoxil | Susceptible | <0.25 |
Imipenem/cilastatin | Susceptible | <1 |
Meropenem | Susceptible | <1 |
Aztreonam | Susceptible | <4 |
Gentamicin | Susceptible | <2 |
Amikacin | Susceptible | <4 |
Minocycline | Susceptible | <2 |
Levofloxacin | Susceptible | <0.5 |
Fosfomycin | Susceptible | <4 |
Sulfamethoxazole-trimethoprim | Susceptible | <2 |